Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.

Authors :: Booth CM
Pater JL
Goss PE
Source :: Cancer [Cancer] 2007 May 01; Vol. 109 (9), pp. 1927-8; author reply 1928.
Publication Year :: 2007

Subjects :: Chemotherapy, Adjuvant
Clinical Trials as Topic
Female
Humans
Neoplasm Recurrence, Local prevention & control
Aromatase Inhibitors therapeutic use
Breast Neoplasms drug therapy
Selective Estrogen Receptor Modulators therapeutic use
Tamoxifen therapeutic use

Full Text Access

Tools